FAKTOR OPTIONSSCHEIN - AMBU Stock

Certificat

DE000PN4AMB0

Market Closed - Deutsche Boerse AG 10:21:00 2024-05-27 am EDT
3.87 EUR -1.28% Intraday chart for FAKTOR OPTIONSSCHEIN - AMBU
Current month+58.61%
1 month+66.09%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes
Date Price Change
24-05-27 3.87 -1.28%
24-05-24 3.92 +2.35%
24-05-23 3.83 0.00%
24-05-22 3.83 +2.41%
24-05-21 3.74 -11.16%

Delayed Quote Deutsche Boerse AG

Last update May 27, 2024 at 10:21 am EDT

More quotes

Static data

Product typeExotic Products
Buy / SellCALL
Underlying AMBU A/S
IssuerLogo Issuer BNP Paribas BNP Paribas
WKN PN4AMB
ISINDE000PN4AMB0
Date issued 2022-05-04
Strike 129 kr
Maturity Unlimited
Parity 1 : 1
Emission price 50
Emission volume N/A
Settlement cash
Currency EUR

Technical Indicators

Highest since issue 60.79
Lowest since issue 0.5
Spread 0.24
Spread %5.83%

Company Profile

Ambu A/S is specialized in the design, production and marketing of medical supplies. Net sales break down by family of products as follows: - single-use endoscopes (56.3%); - emergency care and resuscitation devices (22.9%): mechanical ventilation devices (insufflators, laryngeal masks, facial masks and respiratory bags), secretion aspirators, immobilization devices, etc. In addition, the group sells dummies for first aid training centers; - monitoring and diagnostic devices (20.8%): including electrodes used in the fields of cardiology, neurophysiology and first aid. At the end of September 2023, Ambu A/S had four production sites located in China, Malaysia, the United States and Mexico. Net sales are distributed geographically as follows: Denmark (1.2%), Europe (37.8%), the United States (49.5%), North America (1.3%) and other (10.2%).
Sector
-
More about the company

Ratings for Ambu A/S

Trading Rating
Investor Rating
ESG Refinitiv
B
More Ratings

Consensus: Ambu A/S

Sell
Consensus
Buy
Mean consensus
HOLD
Number of Analysts
6
Last Close Price
129.2 DKK
Average target price
111.2 DKK
Spread / Average Target
-13.97%
Consensus